Johnson & Johnson (JNJ) Ownership
JNJ ownership summary
as of October 18, 2026- Institutions
- 76.7% of shares outstanding
- Insiders
- 0.05% of shares outstanding
- Shares outstanding
- 2.41B
- Float
- 2.41B shares available to trade
- Short interest
- 1.02% 22.1M shares short
- Days to cover
- 3.46 short interest up 1.8% vs prior month
- Institutions 76.75%
- Insiders 0.05%
- Other investors 23.20%
JNJ top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | BlackRock Inc | 8.80% | 212.1M | $54.20B | −1.3M (−0.6%) | June 30, 2026 |
| 2 | Vanguard Capital Management, LLC | 6.52% | 157.2M | $40.18B | +621,004 (+0.4%) | June 30, 2026 |
| 3 | State Street Corp | 5.55% | 133.8M | $34.19B | +299,737 (+0.2%) | June 30, 2026 |
| 4 | Vanguard Portfolio Management, LLC | 2.67% | 64.4M | $16.45B | +856,380 (+1.3%) | June 30, 2026 |
| 5 | Geode Capital Management, LLC | 2.45% | 59.1M | $15.10B | −78,445 (−0.1%) | June 30, 2026 |
| 6 | JPMorgan Chase & Co | 2.42% | 58.3M | $14.90B | −4.8M (−7.6%) | June 30, 2026 |
| 7 | Morgan Stanley - Brokerage Accounts | 1.86% | 44.8M | $11.45B | +87,087 (+0.2%) | June 30, 2026 |
| 8 | NORGES BANK | 1.32% | 31.8M | $8.13B | −1.6M (−4.9%) | June 30, 2026 |
| 9 | State Farm Mutual Automobile Ins Co | 1.31% | 31.6M | $8.07B | — | June 30, 2026 |
| 10 | Northern Trust Corp | 1.19% | 28.8M | $7.36B | −527,605 (−1.8%) | June 30, 2026 |
| 11 | Bank of America Corp | 0.97% | 23.4M | $5.99B | −2.1M (−8.1%) | June 30, 2026 |
| 12 | T. Rowe Price Associates, Inc. | 0.95% | 23.0M | $5.88B | +6.5M (+39.5%) | June 30, 2026 |
| 13 | FMR Inc | 0.94% | 22.6M | $5.77B | −2.2M (−8.8%) | June 30, 2026 |
| 14 | Wellington Management Company LLP | 0.94% | 22.6M | $5.77B | +2.5M (+12.5%) | June 30, 2026 |
| 15 | Bank of New York Mellon Corp | 0.90% | 21.7M | $5.54B | −138,615 (−0.6%) | June 30, 2026 |
| 16 | The Goldman Sachs Group Inc | 0.82% | 19.7M | $5.04B | +1.7M (+9.2%) | June 30, 2026 |
| 17 | Legal & General Group PLC | 0.80% | 19.3M | $4.93B | −60,958 (−0.3%) | June 30, 2026 |
| 18 | Charles Schwab Investment Management Inc | 0.79% | 19.1M | $4.89B | −51,054 (−0.3%) | June 30, 2026 |
| 19 | UBS Asset Mgmt Americas Inc | 0.76% | 18.4M | $4.71B | −1.2M (−6.2%) | June 30, 2026 |
| 20 | Wells Fargo & Co | 0.72% | 17.4M | $4.44B | +448,979 (+2.7%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 8 holders added 13.0M shares and 11 cut 14.0M.
JNJ top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard MStar Total Stk Mkt Idx Invest | 3.17% | 76.5M | $19.55B | −147,694 (−0.2%) | August 31, 2026 |
| 2 | Vanguard 500 Index Investor | 2.63% | 63.3M | $16.17B | −660,060 (−1.0%) | September 30, 2026 |
| 3 | iShares Core S&P 500 ETF | 1.33% | 32.1M | $8.21B | −51,689 (−0.2%) | September 30, 2026 |
| 4 | Fidelity 500 Index | 1.30% | 31.2M | $7.99B | +120,014 (+0.4%) | August 31, 2026 |
| 5 | State Street® SPDR® S&P 500® ETF | 1.23% | 29.6M | $7.56B | — | September 30, 2026 |
| 6 | Vanguard MStar Value Index Investor | 0.95% | 23.0M | $5.87B | −52,514 (−0.2%) | September 30, 2026 |
| 7 | State Street®HlthCrSelSectSPDR®ETF | 0.71% | 17.1M | $4.37B | +53,168 (+0.3%) | September 30, 2026 |
| 8 | Vanguard Dividend Appreciation ETF | 0.57% | 13.6M | $3.48B | +8,013 (+0.1%) | September 30, 2026 |
| 9 | Vanguard Institutional Index I | 0.53% | 12.7M | $3.26B | −121,042 (−0.9%) | September 30, 2026 |
| 10 | Vanguard High Dividend Yield ETF | 0.41% | 9.8M | $2.50B | +26,804 (+0.3%) | September 30, 2026 |
| 11 | American Funds Washington Mutual A | 0.40% | 9.7M | $2.49B | +5.1M (+110.3%) | September 30, 2026 |
| 12 | Vanguard Health Care ETF | 0.30% | 7.3M | $1.85B | +9,326 (+0.1%) | September 30, 2026 |
| 13 | JPMorgan Large Cap Growth I | 0.30% | 7.2M | $1.85B | +440,606 (+6.5%) | August 31, 2026 |
| 14 | Columbia Dividend Income Inst | 0.29% | 7.1M | $1.81B | −13,269 (−0.2%) | August 31, 2026 |
| 15 | Vanguard Health Care Inv | 0.29% | 6.9M | $1.76B | +1.7M (+32.4%) | June 30, 2026 |
| 16 | State Street® SPDR® Port S&P 500® ETF | 0.26% | 6.3M | $1.62B | −4,264 (−0.1%) | September 30, 2026 |
| 17 | Vanguard Equity-Income Inv | 0.24% | 5.9M | $1.50B | −105,404 (−1.8%) | June 30, 2026 |
| 18 | iShares Core S&P 500 ETF USD Acc | 0.24% | 5.7M | $1.47B | +1,324 (+0.0%) | September 30, 2026 |
| 19 | Schwab® S&P 500 Index | 0.22% | 5.4M | $1.38B | +12,059 (+0.2%) | September 30, 2026 |
| 20 | iShares Russell 1000 Value ETF | 0.22% | 5.4M | $1.37B | −8,210 (−0.2%) | September 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
JNJ insider transactions
latest 20| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-26 | Thomas H. Kean, Jr. | Sell | $239.30 | — | — |
| 2026-03-19 | John Boozman | Sell | $237.76 | — | — |
| 2026-03-19 | Richard McCormick | Sell | $237.76 | — | — |
| 2026-03-10 | Lloyd Doggett | Buy | $243.75 | — | — |
| 2026-03-06 | Ro Khanna | Sell | $240.57 | — | — |
| 2026-02-20 | Timothy Schmid | Sell | $245.66 | 1,322 | $324,763 |
| 2026-02-18 | Timothy Schmid | Sell | $244.33 | 22,623 | $5.5M |
| 2026-02-17 | Vanessa Broadhurst | Sell | $243.39 | 6,197 | $1.5M |
| 2026-02-05 | Ro Khanna | Buy | $237.66 | — | — |
| 2026-01-23 | Thomas H. Kean, Jr. | Sell | $220.29 | — | — |
| 2025-12-18 | Julie Johnson | Sell | $208.23 | — | — |
| 2025-12-09 | Lloyd Doggett | Buy | $199.99 | — | — |
| 2025-11-20 | Thomas H. Kean, Jr. | Sell | $203.29 | — | — |
| 2025-11-13 | Julie Johnson | Sell | $195.19 | — | — |
| 2025-11-07 | Ro Khanna | Buy | $186.50 | — | — |
| 2025-11-05 | Richard McCormick | Buy | $186.23 | — | — |
| 2025-10-31 | Lisa C. McClain | Sell | $189.02 | — | — |
| 2025-10-30 | Lisa C. McClain | Sell | $189.05 | — | — |
| 2025-10-30 | Lisa C. McClain | Buy | $189.05 | — | — |
| 2025-10-30 | Ro Khanna | Buy | $189.05 | — | — |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
JNJ shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns JNJ
Institutional investors own 76.7% of Johnson & Johnson's shares and insiders 0.05%. The largest holder is BlackRock Inc with 8.80% of the shares (212.1M), as of June 30, 2026. Among the top 20 institutions, 8 added shares and 11 reduced their stake in the latest filings. Short interest is 1.02% of the float, or 3.46 days of average trading volume. The share count fell 14.3% since 2014.
Related: JNJ analyst forecast, JNJ key metrics, JNJ dividend history. See the JNJ stock overview for the latest quote and news.
JNJ ownership FAQ
Who owns the most Johnson & Johnson stock?
The largest shareholders of Johnson & Johnson are BlackRock Inc (8.80%), Vanguard Capital Management, LLC (6.52%), State Street Corp (5.55%), Vanguard Portfolio Management, LLC (2.67%), Geode Capital Management, LLC (2.45%).
What percentage of Johnson & Johnson is owned by institutions?
Institutions hold 76.7% of Johnson & Johnson's shares outstanding; insiders hold 0.05%.
Which funds own Johnson & Johnson?
The largest fund holders of Johnson & Johnson are Vanguard MStar Total Stk Mkt Idx Invest (3.17%), Vanguard 500 Index Investor (2.63%), iShares Core S&P 500 ETF (1.33%), Fidelity 500 Index (1.30%), State Street® SPDR® S&P 500® ETF (1.23%).
What is Johnson & Johnson's short interest?
22.1M shares of Johnson & Johnson were sold short, 1.02% of the float; at the average daily volume it would take 3.46 days to cover.
Are insiders buying or selling Johnson & Johnson?
Of the latest 20 reported insider transactions in Johnson & Johnson (since October 30, 2025), 7 were purchases and 13 were sales.
How many shares of Johnson & Johnson are outstanding?
Johnson & Johnson has 2.41B shares outstanding, of which 2.41B are in the public float.